Poseida Therapeutics, Inc. is seeking an outstanding candidate to join our immuno-oncology team at La Jolla, San Diego, CA. Prior hands-on experience developing, testing, and/or utilizing CARs is required. The Scientist will design and perform experiments for the development of chimeric antigen receptor (CAR)-T cell therapies against cancer. Investigation will focus on in vitro human cell based immunoassays and the coordination of in vivo rodent models of malignancy. The position will play a critical role in the evaluation and identification of lead CAR technologies for clinical evaluation. The successful candidate will demonstrate excellent oral and written communication skills, work well independently and as part of a team, and be able to work on multiple projects simultaneously. Broad expertise in cellular immunology, tumor immunology, molecular biology, and flow cytometry is required for this role. The position is a hands-on, laboratory-based role with the possibility of direct reports.

Poseida is currently developing CAR-T and gene therapy products for cancer and orphan diseases. Poseida is a pre-IPO company with $30M in Series A financing and is currently partnered with J&J’s Janssen to develop allogeneic CAR-T therapies against cancer. Poseida has entered into a worldwide License Agreement with Janssen to research, develop, manufacture and commercialize licensed products using Janssen Centyrin technology. Centyrins are non-scFv, alternative binders that are fully human and one fifth the size of a traditional scFv. In addition, Poseida boasts best-in-class genome engineering capabilities for stable transgene integration or targeted gene disruption. Proprietary tools include piggyBac™ DNA Modification System (capable of delivering 300kb+ of cargo for stable integration and long-term expression), Footprint-Free™ Gene Editing System, NextGEN™ CRISPR, and XTN™ TALEN, which are synthetic, non-viral, and can be surgically precise. Poseida aims to advance the first CAR-T product against multiple myeloma and gene therapy product against Progressive Familial Intraheptic Cholestasis 3. Please visit for more information.

Required Experience and Skills:

  • PhD or equivalent in immunology, molecular biology, or related field and ≥ 2 years of experience in the field
  • Hands-on experience developing, testing, and/or utilizing CARs
  • Expertise in the characterization, culture, expansion, and manipulation of T cells
  • A detailed knowledge of cellular and/or tumor immunology principles, technologies, and experimental techniques (cell culture, in vitro cellular assays, flow cytometry, etc…)
  • Multi-parameter flow cytometry and proficiency in FACS data analysis programs
  • Functional assays measuring cellular activation, cytokine release, proliferation, and killing
  • Molecular biology, Cloning and PCR technologies, genetic manipulation
  • Electroporation techniques and technologies (Plasmid DNA, IVT RNA)
  • Cell separation technologies (e.g., Miltenyi AutoMACS) and FACS sorting
  • Demonstrated track record in successfully developing and employing in vitro/in vivo models
  • Ability to organize, communicate, and present complex data sets to key stakeholders from diverse backgrounds
  • Excellent oral and communication skills

Preferred Experience and Skills:

  • Genetic manipulation using CRISPRs, TALENs, or ZFNs
  • Strong understanding of transplantation biology and the role of histocompatibility antigens
  • Murine tumor models (genetically engineered or syngeneic)
  • Work with external academic, biotechnology, and contract research organizations
  • Mentor and guide other scientists in the group as needed
  • Previous supervisory skills